BEAM
Beam Therapeutics Inc.
NASDAQ · USHealthcareBiotechnology
$26.64-3.23%
Price as of Jul 20, 2026
BEAM ownership
Beam Therapeutics Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$11.8M
Insider trades by month Buys Sells
Oct
Jan
Feb
Apr
Jun
Jul
Context3-month price -13.1%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Simon Amyofficer: Chief Medical Officer | Sell | 373 | $34.73 |
| Jul 1, 2026 | Evans John M.director, officer: CEO | Sell | 13,421 | $35.13 |
| Jul 1, 2026 | Evans John M.director, officer: CEO | Option | 6,337 | $1.03 |
| Jul 1, 2026 | Evans John M.director, officer: CEO | Sell | 11,579 | $35.91 |
| Jul 1, 2026 | Evans John M.director, officer: CEO | Option | 18,663 | $0.67 |
| Jul 1, 2026 | Evans John M.director, officer: CEO | Option | 25,000 | $1.03 |
| Jul 1, 2026 | Evans John M.director, officer: CEO | Sell | 1,900 | $34.84 |
| Jul 1, 2026 | Evans John M.director, officer: CEO | Sell | 23,100 | $34.26 |
| Jun 29, 2026 | FMR LLC10 percent owner, other: See Remark 1 | Sell | 33,372 | $35.12 |
| Jun 29, 2026 | FMR LLC10 percent owner, other: See Remark 1 | Sell | 251,488 | $35.26 |
| Jun 22, 2026 | Ciaramella Giuseppeofficer: President | Option | 29,000 | $1.03 |
| Jun 22, 2026 | Ciaramella Giuseppeofficer: President | Option | 6,505 | $0.67 |
| Jun 5, 2026 | Guindo Chirfidirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | Shaw Christidirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | Walsh Kathleen Edirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | Fishman Markdirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | COOPER GRAHAM Kdirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | MARAGANORE JOHNdirector | Grant | 19,676 | $29.55 |
| Apr 6, 2026 | Bellon Christineofficer: Chief Legal Officer | Sell | 5,956 | $24.58 |
| Apr 6, 2026 | Evans John M.director, officer: CEO | Sell | 30,078 | $24.58 |
| Apr 6, 2026 | Simon Amyofficer: Chief Medical Officer | Sell | 6,700 | $24.58 |
| Apr 6, 2026 | Ciaramella Giuseppeofficer: President | Sell | 11,810 | $24.58 |
| Apr 6, 2026 | Cavanagh Bethany Jofficer: SVP, Finance and Treasurer | Sell | 3,242 | $24.58 |
| Apr 2, 2026 | Cavanagh Bethany Jofficer: SVP, Finance and Treasurer | Grant | 20,000 | — |
| Apr 2, 2026 | Bellon Christineofficer: Chief Legal Officer | Grant | 20,000 | — |
| Apr 2, 2026 | Ciaramella Giuseppeofficer: President | Grant | 40,000 | — |
| Apr 2, 2026 | Simon Amyofficer: Chief Medical Officer | Grant | 31,750 | — |
| Apr 2, 2026 | Emany Sravan Kumarofficer: Chief Financial Officer | Grant | 31,750 | — |
| Apr 1, 2026 | Evans John M.director, officer: CEO | Grant | 90,000 | — |
| Apr 1, 2026 | Evans John M.director, officer: CEO | Option | 25,000 | $0.67 |
Source: BEAM SEC Form 4 filings, latest Jul 2, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their BEAM positions over the last 6 months (SEC Form 13F).
Increased
177
New positions
107
Reduced
132
Sold out
73
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | Increased | 12.5M | Feb 11, 2026 |
| FMR LLC | Increased | 12.5M | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Reduced | 12.1M | May 12, 2026 |
| FMR LLC | Increased | 11.9M | Feb 17, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 10.1M | May 15, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Unchanged | 10.1M | Feb 17, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 10.1M | Feb 17, 2026 |
| VANGUARD GROUP INC | Reduced | 9.2M | Jan 29, 2026 |
| BLACKROCK, INC. | Increased | 8.5M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 8.5M | Feb 12, 2026 |
| STATE STREET CORP | Increased | 5.7M | May 15, 2026 |
| STATE STREET CORP | Increased | 5.2M | Feb 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4.6M | May 8, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4.5M | May 15, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4.5M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.